Translating Chemotaxis Biology into Development-Ready GPCR Therapeutics for Autoimmune Disease
3:30 pm - Thursday 4th March 2027
- Leveraging chemotaxis biology to identify GPCR targets capable of delivering more precise immune modulation in autoimmune disease
- Applying modern pharmacology and translational strategies to optimize target coverage, exposure and candidate quality before entering the clinic
- Sharing lessons learned from advancing a GPCR therapeutic through IND-enabling development
